Skip to main content
OpenTrials

Clinical trial condition

Uveal Melanoma

Explore clinical trials studying Uveal Melanoma. Study availability and eligibility vary by location and protocol.

77 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Uveal Melanoma trial results

Active, not recruiting

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

NCT05907954

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Moores Cancer Center La Jolla, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 18 locations
View Trial Details
Active, not recruiting

A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma

NCT06717126

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations
  • SSD Tumori Rari e Melanoma Viale Orazio Flacco Bari, Italy
  • IRCSS National Cancer Institute, "G.Pascale" Foundation Dip. CORP-S di Ricerca ed Assistenziale Cute, Melanoma lmmunologia Oncologica Sperimentale e Terapie Innovative Naples, Italy
  • IRCSS Istituto Oncologico Veneto UOS Oncologia 2 del Melanoma Ospedale Busonera Padova, Italy
  • IRCCS Istituto Clinico Humanitas Rozzano, Italy
View all 16 locations
View Trial Details
Active, not recruiting

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

NCT05812027

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +43 more
Locations
  • HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 21 locations
View Trial Details
Active, not recruiting

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

NCT03611868

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +33 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Highlands Oncology Rogers, Arkansas, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
View all 21 locations
View Trial Details
Completed

Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

NCT02678572

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 22 locations
View Trial Details
Completed

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

NCT03070392

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Byers Eye Institute, Stanford University Palo Alto, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View all 57 locations
View Trial Details

Related conditions